COVID Vaccine Response in Patients With Solid Tumors
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Blood Cancer Patients and Covid-19: Higher Risks but Vaccine Ready
physiciansweekly.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from physiciansweekly.com Daily Mail and Mail on Sunday newspapers.
Pfizer-BioNTech’s COVID-19 vaccine effective and safe for use among cancer patients
Researchers in Israel have conducted a study showing that the use of Pfizer-BioNTech’s coronavirus disease 2019 (COVID-19) vaccine appears to be safe and effective among patients with cancer.
“To our knowledge, this study is the first to prospectively characterize the serologic status, immunogenicity, and safety of the BNT162b2 vaccine in a cohort of patients with solid tumors who are receiving active anticancer therapies,” writes the team from the Rambam Health Care Campus, the Rappaport Faculty of Medicine, and the Technion-Integrated Cancer Center, in Haifa.
While the efficacy and safety profiles of COVID-19 vaccines have previously been demonstrated in phase 3 studies, the team says patients with cancer were not adequately represented in these trials.